This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 Aug;18(8):1071-80.

doi: 10.1023/a:1010994022294.

Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--toward a consensus

G T Tucker¹, J B Houston, S M Huang

Affiliations

PMID: 11587475
DOI: 10.1023/a:1010994022294

Review

Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--toward a consensus

G T Tucker et al. Pharm Res. 2001 Aug.

. 2001 Aug;18(8):1071-80.

doi: 10.1023/a:1010994022294.

Authors

G T Tucker¹, J B Houston, S M Huang

Affiliation

¹ Division of Clinical Sciences, University of Sheffield, The Royal Hallamshire Hospital, United Kingdom.

PMID: 11587475
DOI: 10.1023/a:1010994022294

No abstract available

PubMed Disclaimer

Similar articles

Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--towards a consensus.
Tucker GT, Houston JB, Huang SM. Tucker GT, et al. Br J Clin Pharmacol. 2001 Jul;52(1):107-17. doi: 10.1046/j.0306-5251.2001.temp.1441.x. Br J Clin Pharmacol. 2001. PMID: 11453898 Free PMC article. Review. No abstract available.
EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences.
Tucker GT, Houston JB, Huang SM. Tucker GT, et al. Eur J Pharm Sci. 2001 Jul;13(4):417-28. doi: 10.1016/s0928-0987(01)00148-8. Eur J Pharm Sci. 2001. PMID: 11480400 No abstract available.
Transporter-drug interactions and transporter-mediated toxicity in the liver/hepatocyte. Preface.
Krajcsi P, Vereczkey L. Krajcsi P, et al. Drug Metab Rev. 2010 Aug;42(3):379. doi: 10.3109/03602530903492129. Drug Metab Rev. 2010. PMID: 20597844 No abstract available.
Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential-toward a consensus.
Tucker GT, Houston JB, Huang SM. Tucker GT, et al. Clin Pharmacol Ther. 2001 Aug;70(2):103-14. doi: 10.1067/mcp.2001.116891. Clin Pharmacol Ther. 2001. PMID: 11503003 No abstract available.
Drug interactions evaluation: an integrated part of risk assessment of therapeutics.
Zhang L, Reynolds KS, Zhao P, Huang SM. Zhang L, et al. Toxicol Appl Pharmacol. 2010 Mar 1;243(2):134-45. doi: 10.1016/j.taap.2009.12.016. Epub 2010 Jan 4. Toxicol Appl Pharmacol. 2010. PMID: 20045016 Review.

See all similar articles

Cited by

Inhibition of human cytochrome P450 enzymes by hops (Humulus lupulus) and hop prenylphenols.
Yuan Y, Qiu X, Nikolić D, Chen SN, Huang K, Li G, Pauli GF, van Breemen RB. Yuan Y, et al. Eur J Pharm Sci. 2014 Mar 12;53:55-61. doi: 10.1016/j.ejps.2013.12.003. Epub 2013 Dec 14. Eur J Pharm Sci. 2014. PMID: 24342125 Free PMC article.
Effect of single and repeat doses of casopitant on the pharmacokinetics of CYP450 3A4 substrates midazolam and nifedipine.
Zamuner S, Johnson BM, Pagliarusco S, Fina P, Peroni M, Fiore M, Adams LM, Fernandes SA. Zamuner S, et al. Br J Clin Pharmacol. 2010 Oct;70(4):537-46. doi: 10.1111/j.1365-2125.2010.03729.x. Br J Clin Pharmacol. 2010. PMID: 20840445 Free PMC article.
Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry.
Jia L, Wong H, Cerna C, Weitman SD. Jia L, et al. Pharm Res. 2002 Aug;19(8):1091-6. doi: 10.1023/a:1019829622088. Pharm Res. 2002. PMID: 12240933
The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling.
Kato M, Shitara Y, Sato H, Yoshisue K, Hirano M, Ikeda T, Sugiyama Y. Kato M, et al. Pharm Res. 2008 Aug;25(8):1891-901. doi: 10.1007/s11095-008-9607-2. Epub 2008 May 16. Pharm Res. 2008. PMID: 18483837
The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials.
Whitten DL, Myers SP, Hawrelak JA, Wohlmuth H. Whitten DL, et al. Br J Clin Pharmacol. 2006 Nov;62(5):512-26. doi: 10.1111/j.1365-2125.2006.02755.x. Epub 2006 Sep 29. Br J Clin Pharmacol. 2006. PMID: 17010103 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information